The Role of Telehealth in Expanding Access to Healthcare During the COVID-19 Pandemic: Considerations for Vaccine Uptake and Monitoring for Adverse Events

Advanced registration is not required.

Date: Thursday, March 11, 2021

Time: 2:00 PM – 3:00 PM ET

A few minutes before the webinar begins, please click the link below to join:
https://www.zoomgov.com/j/1600341756?pwd=N2JKc3pOcW1lSGdtWUJQVkRjREt0dz09external icon

Webinar ID: 160 034 1756

Passcode: 313248

Dial-in US: +1 669 254 5252  or +1 646 828 7666  or +1 551 285 1373  or +1 669 216 1590

iPhone one-tap: US: +16692545252,,1600341756#,,,,*313248#  or +16468287666,,1600341756#,,,,*313248#

International numbers available: https://www.zoomgov.com/u/aboZZd4AYFexternal icon

Activity-specific Objectives

At the conclusion of the session, the participant will be able to accomplish the following—

1. Discuss CDC’s telehealth guidance and considerations for vaccine planning.
2. Summarize recent discussions with national telehealth providers.
3. Cite current CDC vaccine resources (e.g., V-safe, COVID-19 Vaccine Confidence Consults) and how healthcare facilities can integrate them into existing telehealth services.
4. Describe current telehealth experiences that can inform strategies to build vaccine confidence, address vaccine hesitancy, increase vaccine uptake, and expand vaccine adverse event monitoring.

COCA Call Objectives

1. Cite background information on the topic covered during the presentation.
2. Discuss CDC’s role in the topic covered during the presentation.
3. Describe the topic’s implications for clinicians.
4. Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
5. Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of health care providers.

Vaccine Consultation Tools & Resources

• How to explain mRNA COVID-19 vaccines to patients
• 10 Things Healthcare Professionals Need to Know about U.S. COVID-19 Vaccination Plans;
• Support clinicians to prepare to provide COVID-19 vaccines;
• Vaccine Confidence
  • COVID-19 Vaccination Communication Toolkit: resources designed to educate healthcare teams as well as the tools needed for providers to educate patients.
    • Building confidence among healthcare providers: How to Build Confidence in COVID-19 Vaccines: A Short Guide for Immunization Coordinators in Medical Centers and Clinics, is a great resource.
    • FAQpdf icon for HCPs around the COVID-19 vaccines.
    • Quick Answers for Healthcare Professionals to Common Questions People May Ask about COVID-19 Vaccines pdf icon [2 pages] (cdc.gov)pdf icon. This is a great guide that could help telehealth providers quickly address any common patient questions that might arise.  There are some additional FAQs about the COVID-19 vaccination here as well.  Additionally, this resource on answering patient questions has some great language that providers can use to address common patient questions.
  • COVID-19 Vaccine landing page for all clinical matters related to COVID-19 vaccine and specifically helpful for providers who need more clinical education about the vaccine to help address hesitancy issues in their patients.
  • CDC COVID-19 Support Lines: For Healthcare worker questions. CDC-INFO  800-CDC-INFO (800-232-4636), or the CDC-INFO Submission page
  • Clinicians can also call the above number and ask for the Clinician On-Call Center which provides clinical support. More information on that can be found in this Clinician On-Call Center Documentpdf icon.

• • Confidence Consults: The Consults are designed to provide technical assistance to jurisdictions in building vaccine confidence and promoting COVID-19 vaccine acceptance. This will include practical guidance, sharing existing resources/tools, and linkages to relevant organizations. If facilities or health systems need help tackling confidence issues, they can reach out to their state or local health departments to those states, and in turn, the state/local health departments can reach out to the consult service. You can send an email to confidenceconsults@cdc.gov to request a 60-minute consult with a vaccine confidence SME.

COVID-19 Vaccine Linkage to Administration Sites

• How do I get vaccinated?
• If you are interested in becoming COVID-19 vaccine providers, work with state and local health department for the latest vaccine distribution plans in your region.
• The CDC publishes resources for COVID-19 vaccination provider support.
• CDC’s vaccine order management system
  • Order COVID-19 vaccines using the Vaccine Tracking System (VTrckS)
• CDC’s guidance for COVID-19 vaccine candidates require ultra-cold storage (-60 to -80°C) or cold storage (-20°C).  Vaccine Storage and Handling Toolkit

COVID-19 Vaccine Adverse Event Safety & Monitoring

• V-Safe after Vaccination Health Checker
  • V-safe is a smartphone-based tool that uses text messaging and web surveys to provide personalized health check-ins after you receive a COVID-19 vaccine. Through v-safe, you can quickly tell CDC if you have any side effects after getting the COVID-19 vaccine. Depending on your answers, someone from CDC may call to check on you and get more information. V-safe will also remind you to get your second COVID-19 vaccine dose if you need one.
  • V-safe Frequently Asked Questions (FAQs)
• VaxTextSM COVID-19 Vaccination Second-Dose Reminder
  • VaxText is a free text messaging platform that providers can offer to their patients. Patients can opt in to conveniently receive text message reminders to get their second dose of COVID-19 vaccine. VaxText offers the added benefit of reminding patients to sign up for v-safe, a tool that allows people to report adverse outcomes following vaccination.
• Vaccine Adverse Event Reporting System (VAERS) (hhs.gov)external icon
  • This is a national system is open to the public to collect reports on any adverse events that occur after vaccination. Report any adverse reactions to the VAERS.

COVID-19 Vaccination Clinics (Satellite, Temporary, or Off-Site Location) Resources

• Guidance for Planning Vaccination Clinics | CDC
• Vaccination Clinic Planning Activities | CDC
• Pre-Vaccination Clinic Activities | CDC
• During Vaccination Clinic Activities | CDC
• Post-Vaccination Clinic Activities | CDC
• Checklist of Best Practices for Vaccination Clinics Held at Satellite, Temporary, or Off-Site Locations (izsummitpartners.org)pdf iconexternal icon
• Satellite, Temporary, and Off-Site Vaccination Clinic Supply Checklist | CDC
• Pfizer-BioNTech COVID-19 vaccine fact sheet for patients
• Moderna COVID-19 vaccine fact sheet for patientsexternal icon

To receive continuing education (CE) for WC2922-031121 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – The Role of Telehealth in Expanding Access to Healthcare During the COVID-19 Pandemic: Considerations for Vaccine Uptake and Monitoring for Adverse Events, Thursday, March 11, 2021, please visit TCEO and follow these 9 Simple Steps by Monday, April 12, 2021.

To receive continuing education (CE) for WD2922-031121 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – The Role of Telehealth in Expanding Access to Healthcare During the COVID-19 Pandemic: Considerations for Vaccine Uptake and Monitoring for Adverse Events, Thursday, March 11, 2021, (Web on Demand), please visit TCEO and follow these 9 Simple Steps by Thursday, April 13, 2023.

CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

The Centers for Disease Control and Prevention designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity provides 1.0 contact hour.

CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU’s for this program.

CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 1 Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.

CPE: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This program is a designated event for pharmacists to receive 0.1 CEUs in pharmacy education. The Universal Activity Number is JA4008229-0000-21-021-L04-P and enduring JA4008229-0000-21-022-H04-P course category.

DISCLOSURE:

In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters.

Planners have reviewed content to ensure there is no bias.

The presentation will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC did not accept commercial support for this continuing education activity.

• Physicians
• Nurses
• Pharmacists
• Veterinarians
• Physician Assistants
• Health Educators
• Other Clinicians

System requirements to use Zoomexternal iconexternal icon

• Contact Information:coca@cdc.gov
• Support/Funding:Centers for Disease Control and Prevention, Emergency Risk Communication Branch
• Method of Participation:You may participate in the educational activity by viewing the program information above.